Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02432079 · ClinicalTrials.gov registry record
Molecular Genetics of Heterotaxy and Related Congenital Heart Defects
A clinical trial of Congenital Heart Defects and Heterotaxy Syndrome, sponsored by Indiana University.
- Recruiting
- Registry status
- 2,000
- Enrollment target
- 1
- Study location
NCT02432079: Recruiting study of Congenital Heart Defects and Heterotaxy Syndrome, sponsored by Indiana University.
NCT02432079 is a study of Congenital Heart Defects and Heterotaxy Syndrome that is actively recruiting participants, run by Indiana University. The registered enrollment target is 2,000 participants, below the 10,747-participant average among 3 other Congenital Heart Defects trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02432079, a study of Congenital Heart Defects and Heterotaxy Syndrome, is actively recruiting participants, sponsored by Indiana University.
- RECRUITING
- Registry status
- 2,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to obtain specimens and data from individuals and their families with heterotaxy and related congenital heart defects in order to clarify the molecular genetics of this disorder. The knowledge gained from the analysis of this information will provide the basis for future genetic counseling as well as contribute to knowledge about the biology of normal and abnormal development of left-right anatomic asymmetry.
Primary Outcome
These results will provide important information on the causes, management, and prognosis of heterotaxy and related congenital heart defects. This will provide the basis for future genetic testing and genetic counseling as well as contribute to knowledge about the biology of normal and abnormal development of left-right asymmetry.
Conditions Studied
Study Locations (1)
Indiana
- Indiana University School of Medicine - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2009-07 |
| Est. Completion | 2030-12 |
What NCT02432079 shows while recruiting
NCT02432079 is an observational study that tracks outcomes without assigning an intervention. Its 2,000 participants enrollment target places it among the larger protocols in the corpus, below the 10,747-participant average among 3 other Congenital Heart Defects trials with a reported enrollment target (81% lower).
The record links to 2 conditions, with Congenital Heart Defects appearing as the primary indexed condition, and to 0 interventions.
NCT02432079 reports a single indexed study location in Indiana.
Frequently Asked Questions
What is clinical trial NCT02432079 about?
NCT02432079 is a clinical study titled "Molecular Genetics of Heterotaxy and Related Congenital Heart Defects". The goal of this study is to obtain specimens and data from individuals and their families with heterotaxy and related congenital heart defects in order to clarify the molecular genetics of this disorder. The knowledge gained from the analysis of this information will provide the basis for future ge...
What is the current status of trial NCT02432079?
This trial is currently recruiting. The enrollment target is 2,000 participants. The study started on 2009-07. Estimated completion is 2030-12.
What conditions does trial NCT02432079 study?
This clinical trial studies the following conditions: Congenital Heart Defects, Heterotaxy Syndrome.
Who is sponsoring clinical trial NCT02432079?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02432079 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Congenital Heart Defects
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001465 · 2,000 participants
Study of the Disease Process of Lymphangioleiomyomatosis
- NCT00001595 · 2,000 participants
An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
- NCT00138931 · 2,000 participants
Genetics of Cardiovascular and Neuromuscular Disease
- NCT00288119 · 2,000 participants
Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia